Cross-sectional retrospective analysis of clinical characteristics of chronic hepatitis B patients with oral antiviral treatment in eastern China

摘要

In China, more than 20 million patients with chronic hepatitis B need antiviral treatment. Side effects of antiviral treatment such as renal complications can be problematic, particularly in an aging population. The data were retrospectively extracted from the hospital medical charts of five centers in eastern China from January 1 to December 31, 2018. A total of 8309 patients with CHB was enrolled in this study. The median age of the patients was 46?years. The prevalence of diabetes mellitus, hypertension, and hepatic cirrhosis was respectively 3.49%, 4.42%, and 23.72%. The prevalence of these comorbidities increased with age (P??0.001). Of the patients with CHB, 5332 had complete renal function results. Among them, patients with an estimated glomerular filtration rate of??60?mL/min/1.73m2 accounted for 4.14%, and those with proteinuria for 8.33%. According to the definition of chronic kidney disease, the proportion of patients with chronic kidney disease was 11.37%. The prevalence of chronic kidney disease increased with age (P??0.001). In a multivariate analysis, age group [odds ratio (OR)?=?2.387], diabetes mellitus (OR?=?1.486), hypertension (OR?=?2.557), hepatic cirrhosis (OR?=?1.295), and a history of exposure to adefovir dipivoxil (OR?=?1.644) were significantly associated with CKD (P??0.05). Among patients with CKD, 17.66% (107/606) had a history of lamivudine exposure, and 34.65% (210/606) had a history of nucleotide analogue exposure The management of Chinese patients with CHB should take into consideration age, previous medication history, and renal impairment.